NASDAQ:NNNN | Free Cash Flow | Anbio Biotechnology

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$6.74M
2024-12-31$2.08M
2023-12-31$898,367.00
2022-12-31$4.45M